Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature

about

Tissue-Resident Lymphocytes Across Innate and Adaptive Lineages

P2860

Q57300016-DD007C44-259D-4D9F-B5EE-48BEAC29213B

P2860

Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature

Item

http://www.wikidata.org/entity/Q41619501

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature

@en

type

Item

label

Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature

@en

prefLabel

Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature

@en

P1476

Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature

@en

P2093

Lacy E Lowry

http://www.w3.org/2001/XMLSchema#string

William A Zehring

http://www.w3.org/2001/XMLSchema#string

P2860

Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer

NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy

Improving natural killer cell cancer immunotherapy

Cancer immunotherapy comes of age

Heterogeneity in cancer: cancer stem cells versus clonal evolution

Chitosan nanoparticle-based delivery of fused NKG2D-IL-21 gene suppresses colon cancer growth in mice.

Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients

NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.

Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.

P304

1061

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2017.01061

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28919894

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5585139

http://www.w3.org/2001/XMLSchema#string

Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature

about

P2860

P2860

Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932